{"schema_version":"secwatch.filing_event.v1","accession":"0000926617-23-000052","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2023-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.896143+00:00","generated_at":"2026-06-14T08:49:39.914279+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Aspira appoints director, new CFO; regains Nasdaq bid price compliance","bullets":["Dr. Winfred Parnell appointed to board effective June 1, 2023; also named to Nominating & Governance Committee.","Interim CFO Marlene McLennan's term ended May 31, 2023; Dr. Torsten Hombeck to assume CFO role June 15, 2023.","Regained Nasdaq compliance: closing bid price >=$1 for 10 consecutive days through May 25, 2023; matter closed.","Previously disclosed deficiency in June 2022; extension granted until May 29, 2023 was met.","Board determined Parnell meets Nasdaq independence standards."],"urls":{"canonical":"https://secwatch.observer/filing/0000926617-23-000052","json":"https://secwatch.observer/filing/0000926617-23-000052.json","markdown":"https://secwatch.observer/filing/0000926617-23-000052.md","text":"https://secwatch.observer/filing/0000926617-23-000052.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000092661723000052/0000926617-23-000052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000092661723000052/awh-20230526x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T08:49:39.914279+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1a9efa0403","claim":"Dr. Torsten Hombeck was appointed as Chief Financial Officer at Aspira Women's Health Inc..","evidence_excerpt":"As previously announced, Dr. Torsten Hombeck will begin his service as the Company’s Chief Financial Officer on June 15, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000092661723000052/0000926617-23-000052-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will begin his service"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"8786800749","claim":"Marlene McLennan departed as Interim Chief Financial Officer at Aspira Women's Health Inc..","evidence_excerpt":"Effective May 31, 2023, Marlene McLennan’s term as Interim Chief Financial Officer of Aspira Women’s Health Inc. (the “Company”) has come to a close, pursuant to her Employment Agreement with the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000092661723000052/0000926617-23-000052-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"has come to a close"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"ca22b961a1","claim":"Dr. Winfred Parnell was appointed as director at Aspira Women's Health Inc..","evidence_excerpt":"On June 1, 2023, the Company’s Board of Directors (the “Board”) appointed Dr. Winfred Parnell as a director, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000092661723000052/0000926617-23-000052-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}